MALATHION - Generic Drug Details

What are the generic sources for malathion and what is the scope of patent protection?

Malathion is the generic ingredient in two branded drugs marketed by Pharmobedient, Suven Pharms, and Taro, and is included in three NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Malathion has nine patent family members in six countries.

There are three drug master file entries for malathion. Three suppliers are listed for this compound.

Summary for MALATHION

International Patents:	9
US Patents:	2
Tradenames:	2
Applicants:	3
NDAs:	3
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	8
Patent Applications:	6,635
Drug Prices:	Drug price trends for MALATHION
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for MALATHION
What excipients (inactive ingredients) are in MALATHION?	MALATHION excipients list
DailyMed Link:	MALATHION at DailyMed

See drug prices for MALATHION

See drug sales revenues for MALATHION

Recent Clinical Trials for MALATHION

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
London School of Hygiene and Tropical Medicine	Phase 3
Taro Pharmaceuticals USA	Phase 1
Taro Pharmaceuticals USA	Phase 2/Phase 3

See all MALATHION clinical trials

Pharmacology for MALATHION

Drug Class	Cholinesterase Inhibitor
Mechanism of Action	Cholinesterase Inhibitors

Medical Subject Heading (MeSH) Categories for MALATHION

Cholinesterase Inhibitors

Insecticides

Anatomical Therapeutic Chemical (ATC) Classes for MALATHION

P03AX	Other ectoparasiticides, incl. scabicides
P03A	ECTOPARASITICIDES, INCL. SCABICIDES
P03	ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS
P	Antiparasitic products, insecticides and repellents

Paragraph IV (Patent) Challenges for MALATHION

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
OVIDE	Topical Lotion	malathion	0.50%	018613	1	2011-03-16

US Patents and Regulatory Information for MALATHION

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmobedient	MALATHION	malathion	LOTION;TOPICAL	078743-001	Mar 6, 2009		DISCN	No	No
Taro	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No			Y
Suven Pharms	MALATHION	malathion	LOTION;TOPICAL	091559-001	May 23, 2012		RX	No	Yes
Taro	OVIDE	malathion	LOTION;TOPICAL	018613-001	Aug 2, 1982		DISCN	Yes	No			Y	Y

International Patents for MALATHION

Country	Patent Number	Title	Estimated Expiration
Japan	2009500422
Brazil	PI0612686	processo para preparar malation para uso farmacêutico
Japan	2013032405	PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE
Japan	5474347
European Patent Office	1898707	PROCEDE DE PREPARATION DE MALATHION DESTINE A UN USAGE PHARMACEUTIQUE (PROCESS FOR PREPARING MALATHION FOR PHARMACEUTICAL USE)
China	103087095	Process for preparing malathion for pharmaceutical use, and combination thereof

MALATHION Market Analysis and Financial Projection

Last updated: February 13, 2026

What Are the Market Dynamics for Malathion?

Malathion, an organophosphate insecticide, holds a niche in both agriculture and public health sectors. Its significance stems from efficacy in pest control, including mosquito control, agriculture pest management, and urban pest suppression. The global demand for Malathion is influenced by regulatory constraints, environmental concerns, and the development of alternative pest control solutions.

Key Drivers

• Public Health Application: Malathion is used in vector control programs to combat mosquito-borne illnesses such as malaria, dengue, and Zika. These programs typically expand during outbreaks and in regions with high disease prevalence.

• Agricultural Use: Its application in crop protection, particularly in fruits and vegetables, sustains steady demand in regions like Asia Pacific, North America, and parts of Europe.

• Regulatory Shifts: Increasing restrictions on organophosphate insecticides in the European Union (EU) and certain U.S. states limit Malathion’s market access. However, approval remains in several countries, particularly where alternatives are limited.

Regional Market Trends

Region	Market Status	Regulatory Context	Demand Drivers
North America	Moderate demand	EPA restrictions on residential use; permits in vector control	Mosquito control; agriculture
Europe	Declining demand	EU bans on organophosphates; heavily restricted in residentials	Limited, primarily industrial use
Asia Pacific	Growing demand	Less restrictive; rapid urbanization and agriculture needs	Urban vector control; crop protection
Latin America	Stable demand	Generally fewer restrictions; reliance on Malathion in vector control	Public health campaigns

Challenges Affecting Market Dynamics

1. Regulatory Restrictions: EU bans and U.S. residential use restrictions minimize Malathion's domestic market. These shifts influence global trade flows.

2. Environmental Hazards: Concerns over toxicity to non-target species, particularly pollinators and aquatic life, lead to regulatory and public resistance.

3. Competition from Alternatives: Pyrethroids, neonicotinoids, and biological agents are replacing Malathion in numerous applications.

4. Resistance Development: Overuse in vector control programs sometimes leads to pest resistance, reducing efficacy and increasing operational costs.

What Is the Financial Trajectory for Malathion?

Revenue projections for Malathion vary based on regulatory environments, regional demand, and competitive landscape.

Revenue Estimates and Market Size

• Global Market Size (2022): Estimated at approximately $250 million, with North America constituting roughly 35%, Asia Pacific 40%, and Europe less than 10%, with the remainder in Latin America and other regions.

• Growth Rate: Compound annual growth rate (CAGR) projected at 2-3% for the next five years, primarily driven by Asia Pacific's expanding agricultural and urban pest control markets.

• Breakdown: The public health sector in developing nations could showcase higher growth, estimated at 4-5% CAGR, due to vector-borne disease control efforts.

Major Market Players

• Sipcam and Makhteshim Agan have historically been key suppliers, though market fragmentation persists.

• Government Contracts: Public sector procurement accounts for a significant portion of Malathion sales in regions with active mosquito control programs.

Price Trends

• Pricing: Generally stable but can decline under increased regulation or when cheaper, alternative products enter the market.

• Cost Factors: Raw material prices, regulatory compliance costs, and supply chain influences significantly impact profit margins.

Future Financial Outlook

• Declining demand in Europe and the US suggests limited growth potential in developed markets.
• Rising demand in Asia Pacific for vector control and agriculture presents incremental opportunities.
• Innovation in formulations and combination products could sustain some revenue stability.

Summary of Key Market and Financial Insights

• Malathion remains relevant where alternatives are not affordable or available.
• Regulatory environments are the dominant factor influencing market size and growth.
• Asia Pacific presents the highest potential for expansion amid increasing urbanization.
• Revenue growth prospects are limited but supported by public health needs in developing nations.

Key Takeaways

• Regulatory restrictions in Europe and parts of North America curb the market but do not eliminate it.
• The primary drivers are vector control programs and crop protection in Asia Pacific.
• Competition from other chemical classes and resistance development challenge Malathion's market share.
• The global market is relatively fragmented, with several regional players.
• Future revenue primarily depends on regional disease control initiatives and agricultural demand.

FAQs

1. How does regulation impact Malathion’s market?
Restriction on organophosphates in Europe and the U.S. limits usage, especially in residential and urban pest control. Regulatory approvals in developing countries sustain demand wallowing in larger markets.

2. What are the main applications of Malathion?
Malathion is used for mosquito control, agricultural pest management, and urban pest control, particularly in regions with high vector-borne disease prevalence.

3. How is the market expected to evolve?
Growth is expected to be slow in developed markets due to regulation and environmental concerns but remains steady in Asia Pacific and Latin America.

4. Who are the leading market players?
Manufacturers like Sipcam and Makhteshim Agan are dominant, but market fragmentation means multiple regional suppliers operate.

5. What alternative solutions threaten Malathion’s market?
Pyrethroids, neonicotinoids, and biological agents increasingly replace Malathion due to environmental and resistance issues.

---

Sources

1. MarketWatch, "Global Malathion Market Size," 2023.
2. EPA, "Regulation of Organophosphate Insecticides," 2022.
3. European Chemicals Agency (ECHA), "Restrictions on Organophosphates," 2022.
4. FAO, "Pest Control and Insecticide Use," 2023.
5. Industry Reports, "Insecticide Market Dynamics," 2023.